Literature DB >> 12128091

Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins.

Craig S Atwood1, Ralph N Martins, Mark A Smith, George Perry.   

Abstract

Amyloid deposits are primarily composed of the amyloid-beta protein, although other proteins (and metal ions) also have been colocalized to these lesions. The pattern of oxidative modifications in amyloid plaques is very different to that associated with neurofibrillary tangles and neuronal cell bodies, likely reflecting the different composition of these structures, accessibility of oxidants, the generation of oxidants in and around these structures and the intrinsic antioxidant defense systems to protect these structures. Future studies directed at understanding Abeta interactions with other amyloid components, the role of oxidative modifications in stabilizing amyloid deposits and the determination of protease cleavage sites on Abeta may provide mechanistic insights regarding both amyloid formation and removal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12128091     DOI: 10.1016/s0196-9781(02)00070-0

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  42 in total

1.  Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD).

Authors:  Walter J Lukiw; Bhattacharjee Surjyadipta; Prerna Dua; Peter N Alexandrov
Journal:  Int J Biochem Mol Biol       Date:  2012-03-20

Review 2.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

Review 3.  Metal protein attenuating compounds for the treatment of Alzheimer's dementia.

Authors:  Elizabeth L Sampson; Lydia Jenagaratnam; Rupert McShane
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

4.  N-Terminal Modified Aβ Variants Enable Modulations to the Structures and Cytotoxicity Levels of Wild-Type Aβ Fibrils through Cross-Seeding.

Authors:  Zhi-Wen Hu; Dan Fai Au; Letticia Cruceta; Liliya Vugmeyster; Wei Qiang
Journal:  ACS Chem Neurosci       Date:  2020-07-06       Impact factor: 4.418

Review 5.  The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms.

Authors:  Hannah Harvey; Szonya Durant
Journal:  Exp Brain Res       Date:  2014-09-03       Impact factor: 1.972

Review 6.  Mitochondria-associated ER membranes and Alzheimer disease.

Authors:  Estela Area-Gomez; Eric A Schon
Journal:  Curr Opin Genet Dev       Date:  2016-05-25       Impact factor: 5.578

7.  Arginine and disordered amyloid-β peptide structures: molecular level insights into the toxicity in Alzheimer's disease.

Authors:  Orkid Coskuner; Olivia Wise-Scira
Journal:  ACS Chem Neurosci       Date:  2013-10-08       Impact factor: 4.418

8.  Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents.

Authors:  Sang-Pil Lee; Maria F Falangola; Ralph A Nixon; Karen Duff; Joseph A Helpern
Journal:  Magn Reson Med       Date:  2004-09       Impact factor: 4.668

9.  Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.

Authors:  Zhiping Mi; Willi Halfter; Eric E Abrahamson; William E Klunk; Chester A Mathis; Elliott J Mufson; Milos D Ikonomovic
Journal:  J Neuropathol Exp Neurol       Date:  2016-07-21       Impact factor: 3.685

10.  Degradation of amyloid beta protein by purified myelin basic protein.

Authors:  Mei-Chen Liao; Mahiuddin Ahmed; Steven O Smith; William E Van Nostrand
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.